Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $144.12, ...

In this article, we will look at where Merck & Co. Inc. (NYSE:MRK) ranks among the most undervalued quality stocks to buy according to analysts. Are More Rate Cuts Necessary to Maintain The ...

On Oct. 1 and 2, the American Chemical Society held its 21st annual Pharma Leaders Conference, hosted this year at the Merck & Co. campus in Rahway, New Jersey. Leaders in medicinal chemistry from ...

We recently published a list of 7 Most Profitable Cheap Stocks To Invest In. In this article, we are going to take a look at ...

Merck & Co is among the partners behind a consortium testing the potential to deliver temperature-controlled medicines and vaccines using a drone. The consortium is led by the humanitarian aid ...

dividend-frequency { font-size: 12px; color: #6c757d; } When closely examining Merck & Co, the following trends emerge: A Price to Earnings ratio of 21.84 significantly below the industry average ...

A Phase IIb/III trial with infants entering their first respiratory syncytial virus (RSV) season met its primary endpoints.

Merck KGaA cut its mid-term sales growth target for its health-care division after a number of high-profile drug trial ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.10% of ...

Across the recent three months, 8 analysts have shared their insights on Merck & Co (NYSE:MRK), expressing a variety of opinions spanning from bullish to bearish. The following table summarizes ...

**NM signifies a non meaningful value. A dash signifies the data is not available.